CNS Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:CNSP) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 7.41 M8.7 M13.75 M14.51 M11.87 M Total liabilities 4.06 M2.52 M2.78 M1.38 M1.96 M Total equity 3.35 M6.18 M10.97 M13.12 M9.91 M Total liabilities & shareholders' equities 7.41 M8.7 M13.75 M14.51 M11.87 M Total debt ————— Net debt —————

ニュース

CNS Pharmaceuticals appoints three new executives to leadership team

CNS Pharmaceuticals’ new CEO outlines strategic overhaul

Corero Network Securityが進化する攻撃パターンに対応しDDoS保護プラットフォームを強化

Corero Network Security reports DDoS protection platform enhancements

CNS ファーマシューティカルズ株価、CEO辞任を受け下落

CNS Pharmaceuticals stock falls after CEO steps down

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco

CNSファーマシューティカルズ、年次株主総会で株式増加と取締役選任を承認

CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting

CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript

コレロ・ネットワーク・セキュリティ、第3四半期の受注高成長を報告

Corero Network Security reports Q3 order intake growth